- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06072924
K01 Impacts of Lingual Endurance Exercise
October 2, 2023 updated by: Brittany Krekeler, University of Cincinnati
Impact of Lingual Endurance Exercise on Rehabilitation of Swallowing Impairments After Ischemic Stroke
Swallowing impairments (dysphagia) frequently occur after stroke and have devastating consequences on overall health and quality of life, and long-term deficits in swallow function also increase risk of morbidity (e.g.
depression) and mortality (i.e.
aspiration pneumonia).
As such, rehabilitation of swallow function to improve safety and efficiency of swallowing is essential in this population.
This study aims to: 1) Provide preliminary data to evaluate the effect of a novel lingual endurance exercise on swallow function in individuals with post-stroke dysphagia; and 2) Collect preliminary data regarding changes in white matter tract diffusion and cortical thickness and from MRI data to better understand effects of lingual exercise training on neuroplasticity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This pilot trial will evaluate the effect of lingual endurance exercise (vs sham exercise) on recovery of swallow function after stroke.
The Primary Aim of this study is to evaluate effects of lingual endurance exercise vs sham on swallow function in individuals with post-stroke dysphagia.
The investigators hypothesize that lingual endurance training will result in greater improvement in measures of oral swallow physiology as compared to sham.
Regardless of outcome, this dataset will provide innovative and highly novel information regarding the relationship between lingual function, swallowing impairments, and cortical representation of dysphagia in a post stroke population.
These pilot data will be essential in providing sufficient power for designing an R01 Phase II intervention trial to investigate how to maximize gains with timing and intensity of therapy delivery to better recover swallow function after stroke.
Study Type
Interventional
Enrollment (Estimated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna Hopkins, MS
- Phone Number: +1 513 558 4152
- Email: hopkiak@ucmail.uc.edu
Study Contact Backup
- Name: Rebecca Reinert
- Phone Number: +1 513 558 1719
- Email: gibsonrk@ucmail.uc.edu
Study Locations
-
-
Ohio
-
Cincinnati, Ohio, United States, 45220
- Recruiting
- University of Cincinnati
-
Principal Investigator:
- Brittany Krekeler, PhD
-
Contact:
- Anna Hopkins, MS
- Phone Number: 513-558-4152
- Email: hopkiak@ucmail.uc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1) 3-6 months since most recent diagnosis of ischemic, non-hemorrhagic stroke occurring in areas involving anterior or posterior circulation and affecting underlying cortical or subcortical structures (including brainstem)
- 2) able to tolerate some oral intake required for assessment of swallowing function via modified barium swallow study (MBSS) 4) able to follow 2-step commands.
- 3) MBSImP Oral Total (OT) score >10 on Modified Barium Swallow Study (MBSS)
Exclusion Criteria:
- 1) ≤18 years of age
- 2) history of dysphagia prior to or after the stroke caused by any of the following conditions: gastrointestinal disease, traumatic brain injury, head and neck cancer, surgery involving the pharynx or larynx
- 3) history of other neurological disease (i.e. multiple sclerosis, ALS, Parkinsons, dementia).
- 4) Any history of dysphagia from prior stroke will be exclusionary.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lingual Endurance Exercise
The experimental exercise group will participate in 3 training sessions per day for 8 weeks.
Endurance exercise will include completing isotonic endurance repetitions 3 times a day.
Number of repetitions per session will be determined during baseline testing for each participant.
|
Pressing tongue against a pressure sensor at the set number of repetitions per session (individualized per participant) 3 times per day
|
Sham Comparator: Sham Exercise
The sham control group will be instructed to press the lingual sensor 30 times at a very low-pressure threshold (1-5 kPa), which will be monitored weekly via device output sent to the study team to avoid use of excessive force that would qualify as exercise (>5 kPa).
|
Pressing tongue against pressure sensor at a low threshold (1-5kPa) 30x/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Barium Swallow Study Impairment Profile Oral Total (MBSImP OT Score)
Time Frame: Change from Baseline (at the end of 8 weeks)
|
MBSImP is a validated, standardized tool for assessing oral, pharyngeal, and esophageal swallowing function.
We will be using change in OT score (sum of components 1-6) as our primary outcome measure.
|
Change from Baseline (at the end of 8 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Normalized Residue Ratio Scale (NRRS)
Time Frame: Change from Baseline (at the end of 8 weeks)
|
Measure of swallow efficiency by calculating the amount of residue remaining after a swallow
|
Change from Baseline (at the end of 8 weeks)
|
Penetration Aspiration Scale (PAS) Scores
Time Frame: Change from Baseline (at the end of 8 weeks)
|
8-point rating scale that is used to capture both degree and sensation of penetration and aspiration
|
Change from Baseline (at the end of 8 weeks)
|
Adherence
Time Frame: At the end of 8 weeks
|
number of repetitions attempted/total number of repetitions prescribed
|
At the end of 8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in fractional anisotropy (FA)
Time Frame: Change from Baseline (at the end of 8 weeks)
|
Diffusion Tensor Imaging (DTI) has been the most common analysis framework that is used to analyze the signal from diffusion MRI (dMRI) to gather information about the properties of the underlying white matter.
|
Change from Baseline (at the end of 8 weeks)
|
Change in cortical thickness
Time Frame: Change from Baseline (at the end of 8 weeks)
|
Diffusion Tensor Imaging (DTI) has been the most common analysis framework that is used to analyze the signal from diffusion MRI (dMRI) to gather information about the properties of the underlying white matter.
|
Change from Baseline (at the end of 8 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2023
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2028
Study Registration Dates
First Submitted
September 19, 2023
First Submitted That Met QC Criteria
October 2, 2023
First Posted (Estimated)
October 9, 2023
Study Record Updates
Last Update Posted (Estimated)
October 9, 2023
Last Update Submitted That Met QC Criteria
October 2, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Gastrointestinal Diseases
- Pharyngeal Diseases
- Otorhinolaryngologic Diseases
- Esophageal Diseases
- Stroke
- Ischemic Stroke
- Deglutition Disorders
Other Study ID Numbers
- 2023-0582 Lingual Endurance
- 1K01HD111680-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is not a plan currently to share IPD with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Medtronic Cardiac Rhythm and Heart FailureMedtronic Bakken Research CenterCompletedCryptogenic Symptomatic Transient Ischemic Attack | Cryptogenic Ischemic StrokeNetherlands, United States, France, Belgium, Germany, Sweden, Italy, Austria, Canada, Denmark, Finland, Greece, Slovakia, Spain
-
University Hospital, BrestCompletedStroke, Ischemic | Stroke HemorrhagicFrance
-
Umbria Bioengineering TechnologiesRecruitingStroke, Ischemic | Stroke HemorrhagicItaly
-
Sheffield Teaching Hospitals NHS Foundation TrustUnknownFatigue | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Australia, Sweden, Canada, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, China, Greece, Japan, Turkey, Netherlands, Romania, United Kingdom, Portugal, Hungary, Italy, Brazil, France, S... and more
-
University of AlbertaCompletedTransient Ischemic Attack | Minor Ischemic StrokeCanada
-
Stephanie HarrisonActive, not recruitingTransient Ischemic Attack | Stroke, IschemicUnited Kingdom
Clinical Trials on Isotonic Endurance Exercise
-
University of CincinnatiCompletedStroke, Ischemic | Dysphagia, Oral PhaseUnited States
-
Riphah International UniversityCompleted
-
Norwegian University of Science and TechnologyLHL-Klinikkene, Røros; LHL-Klinikkene, FeiringWithdrawnVentricular Dysfunction, Left | Heart Failure, DiastolicNorway
-
University of TorontoCompleted
-
University of Illinois at Urbana-ChampaignNational Heart, Lung, and Blood Institute (NHLBI)CompletedVascular Health | Autonomic FunctionUnited States
-
Rigshospitalet, DenmarkCompleted
-
Charite University, Berlin, GermanyUnknown
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University Hospital Inselspital, BerneFederal Office of Sports, SwitzerlandCompletedMyocardial Ischemia | Heart Failure | Exercise | Myocardial Stunning | Myocardial ContractionSwitzerland
-
Comenius UniversityUniversity of Roma La Sapienza; University of Primorska; University of Padova; Physiko-...Recruiting